BRPI0417796A - preparado efervescente de uma substáncia básica de efeito medicinal - Google Patents

preparado efervescente de uma substáncia básica de efeito medicinal

Info

Publication number
BRPI0417796A
BRPI0417796A BRPI0417796-7A BRPI0417796A BRPI0417796A BR PI0417796 A BRPI0417796 A BR PI0417796A BR PI0417796 A BRPI0417796 A BR PI0417796A BR PI0417796 A BRPI0417796 A BR PI0417796A
Authority
BR
Brazil
Prior art keywords
medicinal effect
preparation
effervescent
basic substance
effervescent preparation
Prior art date
Application number
BRPI0417796-7A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Irene Loose
Ralf Buellesbach
Dieter Rehn
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0417796A publication Critical patent/BRPI0417796A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

"PREPARADO EFERVESCENTE DE UMA SUBSTáNCIA BáSICA DE EFEITO MEDICINAL". A presente invenção refere-se a um preparado efervescente contendo uma formulação efervescente, pelo menos uma substância básica de efeito medicinal, e opcionalmente uma ou mais outras substâncias-ativas, caracterizado pelo fato de que é evitada uma alcalinização da urina e assim uma acumulação reforçada da substância ativa básica de efeito medicinal, medicamento contendo esse preparado efervescente, processo para sua preparação e seu emprego.
BRPI0417796-7A 2003-12-19 2004-12-07 preparado efervescente de uma substáncia básica de efeito medicinal BRPI0417796A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz
PCT/EP2004/013886 WO2005063199A1 (de) 2003-12-19 2004-12-07 Brausezubereitung einer basischen arzneilich wirksamen substanz

Publications (1)

Publication Number Publication Date
BRPI0417796A true BRPI0417796A (pt) 2007-03-20

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417796-7A BRPI0417796A (pt) 2003-12-19 2004-12-07 preparado efervescente de uma substáncia básica de efeito medicinal

Country Status (16)

Country Link
EP (1) EP1696874A1 (pt)
JP (1) JP2007515418A (pt)
KR (1) KR20060109492A (pt)
CN (1) CN1893920A (pt)
AR (1) AR046955A1 (pt)
AU (1) AU2004308590A1 (pt)
BR (1) BRPI0417796A (pt)
CA (1) CA2550342A1 (pt)
DE (1) DE10359790A1 (pt)
EC (1) ECSP066649A (pt)
IL (1) IL176356A0 (pt)
MA (1) MA28276A1 (pt)
MX (1) MXPA06006658A (pt)
NO (1) NO20063327L (pt)
WO (1) WO2005063199A1 (pt)
ZA (1) ZA200604946B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
KR101057640B1 (ko) * 2009-05-27 2011-08-18 (주)다산메디켐 발포성 층을 포함하는 다층 정제
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
CA2550342A1 (en) 2005-07-14
ZA200604946B (en) 2007-09-26
NO20063327L (no) 2006-07-18
CN1893920A (zh) 2007-01-10
JP2007515418A (ja) 2007-06-14
ECSP066649A (es) 2006-10-25
IL176356A0 (en) 2006-10-05
KR20060109492A (ko) 2006-10-20
EP1696874A1 (de) 2006-09-06
AU2004308590A1 (en) 2005-07-14
WO2005063199A1 (de) 2005-07-14
MA28276A1 (fr) 2006-11-01
MXPA06006658A (es) 2006-08-31
DE10359790A1 (de) 2005-07-21
AR046955A1 (es) 2006-01-04

Similar Documents

Publication Publication Date Title
BR9908488A (pt) Composição farmacêutica de topiramato
BR9909903A (pt) Eficácia máxima de substâncias usadas para melhorar a saúde e bem-estar
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
BRPI0410503B8 (pt) composição tópica e uso da composição
BR0316906A (pt) administração do capsaicinoides
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
BRPI0418029B8 (pt) formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
GT200200188A (es) Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
BRPI0414435A (pt) métodos e reagentes para o tratamento de distúrbios imunoinflamatórios
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
BR9912179A (pt) Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão
BR0308316A (pt) Sais de nateglinida
BR0210650A (pt) Tablete, e, uso do mesmo
BR9915694A (pt) Composições compreendendo cefuroxima axetil
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
BRPI9910024B8 (pt) uso de uma mistura de alcoóis de açúcar contendo 6-o-alfa-d-glicopiranosil-d-sorbitol (1,6-gps) e 1-o-alfa-d-glicopiranosil-d-manitol (1,1-gpm) in vitro, e composição farmacêutica para consumo humano ou animal
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BRPI0418017A (pt) medicamento compreendendo inibidores de pentraxina ptx3 longa
BR0309412A (pt) Indol-2-onas como inibidores seletivos da ciclooxigenase-2
PT1368016E (pt) Formas de dosagem parenterica que compreendem uma suspensao de sal de tramadol e sal de diclofenac
BR0306778A (pt) Derivados de carboxamidina e seu uso no tratamento de doenças vasculares

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.